^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
MelaNodal Predict™

Type:
Laboratory Developed Test
Related tests:
Evidence

News

11ms
Quest Diagnostics debuts MelaNodal Predict™ Test, personalizing melanoma risk prediction to help patients forgo invasive surgery (Quest Diagnostics Press Release)
"Quest Diagnostics...announced the launch of MelaNodal Predict™, a highly advanced predictive gene expression test to help personalize treatment decisions for patients with melanoma, the deadliest form of skin cancer and one of the most common cancers in the United States. Dermatologists and other providers nationwide may begin ordering the test today from Quest Diagnostics, as well as through Dermpath Diagnostics, Quest's subspecialty pathology business."
Launch
|
MelaNodal Predict™